Inflammatory bowel disease and prostate cancer: from epidemiological controversy to mechanistic hypotheses
Inflammatory bowel disease (IBD) is a chronic systemic inflammatory disorder with rising global prevalence. Epidemiological evidence linking IBD to prostate cancer (PCa) risk remains conflicting. Observational cohorts suggest a possible elevated risk, though this remains uncertain and may be influenced by detection bia...